It’s been a landmark two weeks for the industry. The US FDA and the UK MHRA have taken monumental steps to reduce regulatory uncertainty, one of the biggest barriers to the adoption of non animal methods, also known as New Approach Methodologies (NAMs). In this news post, we discuss how recent MHRA and FDA non-animal … Continue reading Do MHRA and FDA guidelines on non-animal methods in drug development align?